WebQuit Online Smoking Cessation Study

Smoking Clinical Trial

— WebQuit  

Official title:

WebQuit Online Smoking Cessation Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01166334
• Other study ID #: FHCRC IR#7181
• Status: Completed
• Phase: Phase 1
• First received: July 19, 2010
• Last updated: October 10, 2013
• Start date: June 2010
• Est. completion date: January 2012

Study information

• Verified date: October 2013
• Source: Fred Hutchinson Cancer Research Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Would you like to quit smoking?

Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn which of these programs is the most effective at helping people stop smoking. Findings from this study will be used to help build more effective online smoking cessation programs in the future.

Participants in both of the smoking cessation programs used in this study will receive:

• Interactive tools for dealing more effectively with urges to smoke

• Step-by-step guides for quitting smoking

• Personalized plans for quitting and remaining smoke-free

• Electronic links for reaching one-on-one expert help for quitting

Participants will be asked to complete online questionnaires, including a brief three-month follow-up survey.

There is no cost for participating in this study.

To enroll in this study or for more information, please visit www.webquit.com.

This study is being conducted by Seattle's Fred Hutchinson Cancer Research Center (www.fhcrc.org), a world leader in advancing the prevention, diagnosis and treatment of cancer. The principal investigator for the WebQuit smoking cessation study is Dr. Jonathan Bricker, a faculty member at both the Hutchinson Center and at the University of Washington in Seattle.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 721
• Est. completion date: January 2012
• Est. primary completion date: January 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 or older

• a current resident of the US

• someone who has smoked daily for at least the past 12 months

• someone who wants to quit smoking in the next 30 days

• willing and able to read in English

• able to connect to the Internet for at least one hour per week for three consecutive months

• able to use a website

• not participating in other smoking cessation interventions

• willing and able to complete a Baseline Survey

• willing to be randomized to either online program

Exclusion Criteria:

• inability to meet inclusion criteria

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Smoking

Intervention

Behavioral:
• WebQuit study group
Description withheld to protect integrity of study
• WebQuit control group
Identity and description withheld to protect integrity of study

Locations

Country	Name	City	State
United States	Fred Hutchinson Cancer Research Center	Seattle	Washington

Sponsors (1)

Lead Sponsor	Collaborator
Fred Hutchinson Cancer Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	7-day point prevalence	No smoking in the past 7 days, as reported 3 months post treatment.	3 months and 6 months post treatment	No